Perampanel Pharmaceutical Products – Non-Exclusive Discount Agreement

Summary

AOK Sachsen-Anhalt (a German health insurance fund) is establishing non-exclusive discount agreements for finished pharmaceutical products containing Perampanel (ATC: N03AX22), an anticonvulsant medication. Under an open-house model, any qualified pharmaceutical company can enter into a discount contract under uniform conditions without individual negotiations. Contracts run from November 1, 2026 to October 31, 2028 (maximum 24 months), and companies may join at any time on identical terms. This is a transparent procurement published for transparency purposes, not a traditional public tender.